bio-peptide mt2 melanotan MT1 Nasal Spray Melanotan II Research

ISBN 978-0-567-02726-9

This suggests that hyh-derived membranes do not present physical or biochemical alterations interfering with -SNAP binding

[PUBMED Abstract] Eggermont AMM, Blank CU, Mandal M, et al.: Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Consistent with positive data obtained from animal and other pre-clinical studies, several of these phase I/II studies reported trends towards increased disease control and objective response rates, although all were underpowered for detection of efficacy